VERONIKA GAIKWAD: Open Payments
NPI 1356868764 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$839 in 38 payments from 13 companies in 2025. Trend: 2023 $115 · 2024 $231 · 2025 $839
Food & beverage: $797Education: $43
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $196 |
| Tandem Diabetes Care, Inc. | 5 | $123 |
| Mannkind Corporation | 4 | $105 |
| Amgen Inc. | 6 | $104 |
| Abbott Laboratories | 3 | $61 |
| ABBVIE INC. | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| BETA BIONICS, INC. | 2 | $28 |
| Madrigal Pharmaceuticals | 1 | $28 |
Products named: t:slim X2 Insulin Pump with Control-IQ, ZEPBOUND, AFREZZA, MOUNJARO, FREESTYLE LIBRE 3, Kerendia, TEPEZZA, JARDIANCE.
Industry payments across OK — which companies pay providers there.
